Prognostic Factors in Advanced Pancreatic Cancer
Author Information
Author(s): Stocken D D, Hassan A B, Altman D G, Billingham L J, Bramhall S R, Johnson P J, Freemantle N
Primary Institution: Cancer Research UK Clinical Trials Unit, University of Birmingham
Hypothesis
Can a multivariable approach improve the identification of prognostic factors for survival in advanced pancreatic cancer?
Conclusion
The study identified five known and three new prognostic factors for survival in advanced pancreatic cancer, emphasizing the importance of using appropriate statistical models.
Supporting Evidence
- The study confirmed five previously reported prognostic factors: albumin, CA19-9, alkaline phosphatase, LDH, and metastases.
- Three additional factors were identified: WBC, AST, and BUN.
- Nonlinear transformations of continuous variables provided better model fit and insights.
Takeaway
This study looked at what factors can help predict how long people with advanced pancreatic cancer might live, finding some important clues that doctors can use.
Methodology
Data from two phase III randomized controlled trials were analyzed using multivariable models to assess the relationship between various prognostic factors and survival.
Potential Biases
Potential bias due to the retrospective nature of some included studies and the use of different cutoff points across studies.
Limitations
The study relied on data from two trials, which may not represent all patients with advanced pancreatic cancer.
Participant Demographics
The average age of participants was 63 years, with 56% male and 68% having stage IV cancer.
Statistical Information
P-Value
p<0.01 for several factors
Confidence Interval
95% CI: 4.2, 5.1
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website